missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human E-selectin (CD62E) Recombinant Protein
Descripción
This product contains purified recombinant human e-Selectin protein with an N-terminal hexahistidine tag. This product may be used as a positive control in many immunological assays.
Leukocytes adhere to the blood vessel endothelium during extravasation in postcapillary venules of lymph nodes. In addition, leukocyte adhesion occurs in the capillaries and small venules at any site in the body after onset of inflammation. This response is immediate and involves a cascade of adhesion receptors. At the endothelial surface members of the selectin and immunoglobulin superfamilies participate in this cascade. Selectins are C-type cell surface lectins that play a role in leukocyte adhesion to the blood vessel wall endothelium. E-selectin (CD62E) is an endothelial cell specific selectin that is expressed only after activation with proinflammatory cytokines. In vitro experiments have shown that IL-1, TNFalpha and bacterial wall components like lipopolysaccharides induce the transcription of E-selectin in a NFkB dependent signaling cascade. E-selectin has been associated with blood vessel endothelium in diverse inflammatory situations.
Especificaciones
Especificaciones
| Número de acceso | P16581 |
| Concentración | 0.105 mg/mL |
| Para utilizar con (aplicación) | Control, Western Blot |
| Formulación | 0.02 M tris HCl with 100 mM NaCl, 1 mM EDTA, 50% glycerol and no preservative; pH 8 |
| ID de gen (Entrez) | 6401 |
| Nombre | Human E-selectin (CD62E) |
| Cantidad | 1 mg |
| Fuente | E. coli |
| Inmunógeno | N/A |
| Estado normativo | RUO |
| Mostrar más |
Título del producto
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.
¿Detecta una oportunidad de mejora?